The Precision Health Model is a person-centered approach to health that addresses the gaps caused by a “one size fits all” approach to health management.

According to the American Cancer Society, it is estimated that more than two million new cancer cases will be diagnosed and ...

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

Molecular-guided decision-making improves disease control and remission in the treatment of IBD with anti-TNF therapy, ...

At the intersection of radiation and precision, Novartis, Bayer, AstraZeneca and more hope to cash in on a ...

The global oncology blood testing market is on the brink of a major transformation, with projections indicating a significant rise from USD 3,851.7 million in 2022 to USD 18,278.2 million by 2032.

A review now published in the Journal of Experimental & Clinical Cancer Research offers a sweeping and authoritative ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, will present multiple datasets in breast cancer together with its collaborators at the 2025 ESMO Breast Cancer Annual Congress ...

The team is exploring whether biomarker testing could also identify patients who benefit more from immune checkpoint inhibitors after radiation.

Community Oncology Conference empowered attendees with insights on advocacy, innovation, and practical strategies for ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the results of a study ...